Kewaunee Scientific Corporation (KEQU)
Kewaunee Scientific Corporation R&D Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
KEQU R&D Expense Rankings
| Overall | 99th percentile | 13 of 1763 |
| Sector | 99th percentile | 1 of 645 in Technology |
| Industry | 97th percentile | 1 of 45 in Scientific & Technical Instruments |
KEQU R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jul 2007 |
| Maximum | 0.00 | Jul 2007 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these KEQU related companies
KEQU News
Kewaunee Scientific Corp (KEQU) Declares $0.10 Quarterly Dividend; 4.9% Yield
May 30, 3:48PM Street Insider
May 30, 3:48PM Street Insider
Kewaunee Scientific Corp (KEQU) Declares $0.10 Quarterly Dividend; 4.7% Yield
Feb 29, 8:55AM Street Insider
Feb 29, 8:55AM Street Insider
Kewaunee Scientific Corporation Announces Nycom, Inc. Joins Domestic Sales Network
Jan 18, 10:22AM PR Newswire
Jan 18, 10:22AM PR Newswire
Kewaunee Scientific Corporation Announces Significant Business Expansion with ISEC, Inc.
Jan 16, 9:14AM PR Newswire
Jan 16, 9:14AM PR Newswire
Kewaunee Scientific Corp (KEQU) Declares $0.10 Quarterly Dividend; 4.2% Yield
Nov 30, 5:48PM Street Insider
Nov 30, 5:48PM Street Insider
Kewaunee Scientific Corp (KEQU) Reports Q1 Earnings of $0.01; Positive on Sequential Earnings Improvement
Aug 24, 8:05AM Street Insider
Aug 24, 8:05AM Street Insider
Kewaunee Scientific Corp (KEQU) Declares $0.10 Quarterly Dividend; 4.8% Yield
Aug 24, 8:03AM Street Insider
Aug 24, 8:03AM Street Insider
sld $INOD for a 10% loss; sld $KEQU for a 5% loss; sld $PESI for a 15% loss; sld $PRGN at breakeven;
about 336 days ago by txbondman
about 336 days ago by txbondman
This Week's Dividend-Paying Winners and Losers: http://goo.gl/rkWiW / $MRX $OPNT $SLW $TRIB $KEQU $ATNI $WTI $GTY
about 452 days ago by DynamicDividend
about 452 days ago by DynamicDividend
New post on Kewaunee Scientific ($KEQU) from @RationalWalk. Shows companies 10 year track record, margins, etc. http://bit.ly/dB3o5S
about 664 days ago by GeoffGannon
about 664 days ago by GeoffGannon
Playing the gap down on $FUQI, $ADY, $KEQU, $BSX, and $CSKI; here you go: http://linkth.at/068
about 804 days ago by MOFinancial
about 804 days ago by MOFinancial
$KEQU
Brought some KEQU Today at $11.00. I feel KEQU is a great buy at these Levels.
about 1049 days ago by FinancialNerd
about 1049 days ago by FinancialNerd
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| KEQU | 8.25 | -0.02 | -0.24% | 21.28M |
| KEP | 9.40 | -0.12 | -1.26% | 12.22B |
| KEM | 5.58 | -0.16 | -2.79% | 256.35M |
| KELYB | 12.06 | -0.32 | -2.58% | 467.96M |
| KELYA | 11.99 | -0.39 | -3.15% | 456.95M |
| KEG | 9.94 | -0.82 | -7.62% | 1.629B |
| KDN | 22.62 | -0.34 | -1.48% | 733.57M |
| JNPR | 17.26 | -0.14 | -0.83% | 9.164B |
| JNK | 38.53 | -0.18 | -0.46% | |
| JNJ | 62.21 | -0.38 | -0.61% | 171.83B |
